Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Alirocumab
Alirocumab (Praluent®) – Rough Cost Overview (U.S.)
Key take‑away: The wholesale cost per vial is around $600–$650, meaning a typical month’s therapy can cost $1,200–$1,300. Insurance usually covers the bulk of it, leaving the patient with a much smaller copay or deductible.
If you’re unsure, call your pharmacy benefit manager (PBM) or insurer. They can give the exact copay for your plan.
Sanofi Patient Assistance Program (PAP): Offers “Praluent” for eligible patients who meet income criteria. Application link: https://www.sanofi.com/en/patients-support/financial-assistance/praluent
Praluent® Savings Program: Provides discount cards for out‑of‑pocket costs. Apply here: https://www.praluentsavings.com
Bottom line: Alirocumab is a high‑cost specialty drug, but insurance usually covers a large portion. If you’re concerned about the financial burden, explore the patient assistance programs or talk to your prescriber about dosing options. If you need help navigating the paperwork or want to confirm exact numbers for your plan, let me know!
Other Questions About Alirocumab :